The biotechnology sector has experienced a significant rebound in 2025, buoyed by a surge in mergers and acquisitions (M&A). After a prolonged period of...
Small and mid-cap biotech stocks experienced a significant rebound in 2025, driven primarily by a surge in mergers and acquisitions (M&A). According to Dr....